Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells
Tóm tắt
Increased cellular concentration of α-synuclein (α-syn) predisposes it to misfolding and aggregation that in turn impair the degradation pathways. This poses a limitation to the use of overexpression models for studies on α-syn clearance by autophagy, which is widely investigated for its therapeutic potential. This limitation can be overcome with the use of endogenous models. In this study, SK-MEL-28, a melanoma cell model with endogenous α-syn expression, was employed to study α-syn clearance through autophagy. We demonstrated the dual localization of α-syn to nucleus and cytoplasm that varied in response to changes in cellular environment. Autophagy inhibition and exposure to dopamine favored cytoplasmic localization of α-syn, while autophagy induction favored increased localization to the nucleus. The inhibitory effect of dopamine on autophagy was heightened in presence of α-syn. Additionally, because α-syn had a regulatory effect on autophagy, cells showed an increased resistance to autophagy induction in presence of α-syn. This resistance prevented effective induction of autophagy even under conditions of prolonged autophagy inhibition. These results highlight alternate physiological roles of α-syn, particularly in non-neuronal cells. Because autophagy enhancement could reverse neither the increase in α-syn levels nor the autophagy inhibition, there arises a need to evaluate the efficacy of autophagy-based therapeutic strategies.
Tài liệu tham khảo
Asanuma M, Miyazaki I, Diaz-Corrales FJ et al (2013) Transplantation of melanocytes obtained from the skin ameliorates apomorphine-induced abnormal behavior in rodent hemi-parkinsonian models. PLoS One 8:e65983. doi:10.1371/journal.pone.0065983
Barbour R, Kling K, Anderson JP et al (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55–59. doi:10.1159/000112832
Bartels T, Choi JG, Selkoe DJ (2011) α-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107–110. doi:10.1038/nature10324
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310
Colasanti T, Vomero M, Alessandri C et al (2014) Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes. Cell Death Dis 5:e1265. doi:10.1038/cddis.2014.211
Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z et al (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci 31:14508–14520. doi:10.1523/JNEUROSCI.1560-11.2011
Emmanouilidou E, Stefanis L, Vekrellis K (2010) Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging 31:953–968. doi:10.1016/j.neurobiolaging.2008.07.008
Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221:3–12. doi:10.1002/path.2697
Hansen C, Angot E, Bergström A-L et al (2011) α-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121:715–725. doi:10.1172/JCI43366
Hsu LJ, Sagara Y, Arroyo A et al (2000) alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401–410
Irizarry MC, Kim TW, McNamara M et al (1996) Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889–895
Kim C, Lee S-J (2008) Controlling the mass action of alpha-synuclein in Parkinson’s disease. J Neurochem 107:303–316. doi:10.1111/j.1471-4159.2008.05612.x
Kontopoulos E, Parvin JD, Feany MB (2006) Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 15:3012–3023. doi:10.1093/hmg/ddl243
Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38–48. doi:10.1038/nrn3406
Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol JASN 17:1807–1819. doi:10.1681/ASN.2006010083
Lee BR, Matsuo Y, Cashikar AG, Kamitani T (2013a) Role of Ser129 phosphorylation of α-synuclein in melanoma cells. J Cell Sci 126:696–704. doi:10.1242/jcs.122093
Lee H-J, Cho E-D, Lee KW et al (2013b) Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein. Exp Mol Med 45:e22. doi:10.1038/emm.2013.45
Leng Y, Chase TN, Bennett MC (2001) Muscarinic receptor stimulation induces translocation of an alpha-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm. J Biol Chem 276:28212–28218. doi:10.1074/jbc.M011121200
Li L, Chen Y, Gibson SB (2013) Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation. Cell Signal 25:50–65. doi:10.1016/j.cellsig.2012.09.020
Mahmood T, Yang P-C (2012) Western blot: technique, theory, and trouble shooting. North Am J Med Sci 4:429–434. doi:10.4103/1947-2714.100998
Martinez-Vicente M, Cuervo AM (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6:352–361. doi:10.1016/S1474-4422(07)70076-5
Matsuo Y, Kamitani T (2010) Parkinson’s disease-related protein, alpha-synuclein, in malignant melanoma. PLoS One 5:e10481. doi:10.1371/journal.pone.0010481
McLean JR, Hallett PJ, Cooper O et al (2012) Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson’s disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression. Mol Cell Neurosci 49:230–239. doi:10.1016/j.mcn.2011.11.006
Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. Autophagy 3:542–545
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Murase D, Hachiya A, Takano K et al (2013) Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes. J Invest Dermatol 133:2416–2424. doi:10.1038/jid.2013.165
Musgrove REJ, King AE, Dickson TC (2012) α-synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway. Neurotox Res. doi:10.1007/s12640-012-9352-5
Nilsson R, Jain M, Madhusudhan N et al (2014) Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun 5:3128. doi:10.1038/ncomms4128
Oberman Z, Chayen R, Herzberg M (1970) A rapid fluorimetric method for the determination of dopamine in urine. Clin Chim Acta Int J Clin Chem 29:391–394
Oliveras-Salvá M, Van der Perren A, Casadei N et al (2013) rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol Neurodegener 8:44. doi:10.1186/1750-1326-8-44
Outeiro TF, Klucken J, Bercury K et al (2009) Dopamine-induced conformational changes in alpha-synuclein. PLoS One. doi:10.1371/journal.pone.0006906
Pan T, Li X, Jankovic J (2011) The association between Parkinson’s disease and melanoma. Int J Cancer J Int Cancer 128:2251–2260. doi:10.1002/ijc.25912
Pan T, Zhu J, Hwu W-J, Jankovic J (2012) The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One 7:e45183. doi:10.1371/journal.pone.0045183
Roostaee A, Beaudoin S, Staskevicius A, Roucou X (2013) Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization. Mol Neurodegener 8:5. doi:10.1186/1750-1326-8-5
Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443:780–786. doi:10.1038/nature05291
Segura-Aguilar J, Paris I, Muñoz P et al (2014) Protective and toxic roles of dopamine in Parkinson’s disease. J Neurochem 129:898–915. doi:10.1111/jnc.12686
Solomon VR, Lee H (2009) Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625:220–233. doi:10.1016/j.ejphar.2009.06.063
Stefanis L (2012) α-synuclein in Parkinson’s disease. Cold Spring Harb Perspect Med 2:a009399. doi:10.1101/cshperspect.a009399
Suzuki K, Bose P, Leong-Quong RY et al (2010) REAP: a two minute cell fractionation method. BMC Res Notes 3:294. doi:10.1186/1756-0500-3-294
Thoreen CC, Kang SA, Chang JW et al (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284:8023–8032. doi:10.1074/jbc.M900301200
Uversky VN (2008) Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci 9:507–540
Vivacqua G, Casini A, Vaccaro R et al (2011) Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse’s central nervous system by two novel monoclonal antibodies. J Chem Neuroanat 41:97–110. doi:10.1016/j.jchemneu.2010.12.003
Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542–23556. doi:10.1074/jbc.M801992200
Webb JL, Ravikumar B, Atkins J et al (2003) Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278:25009–25013. doi:10.1074/jbc.M300227200
Winslow AR, Chen C-W, Corrochano S et al (2010) α-synuclein impairs macroautophagy: implications for Parkinson’s disease. J Cell Biol 190:1023–1037. doi:10.1083/jcb.201003122
Xilouri M, Vogiatzi T, Vekrellis K et al (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4:e5515. doi:10.1371/journal.pone.0005515
Zhou W, Long C, Reaney SH et al (2010) Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions. Biochim Biophys Acta 1802:322–330. doi:10.1016/j.bbadis.2009.12.004